Cite

HARVARD Citation

    Datta, J. et al. (n.d.). Novel strategy to identify MHC class II-promiscuous CD4+ peptides from tumor antigens for utilization in vaccination. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record